BDBM652725 4-chloro-N6-((2-((3-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazol-6-yl)amino)pyridin- 4-yl)methyl)isoquinoline-1,6-diamine::US20240059691, Example 4440

SMILES Cc1n[nH]c2c1CCC2Nc1cc(CNc2ccc3c(N)ncc(Cl)c3c2)ccn1

InChI Key InChIKey=NPKRAKGSHBIZEI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 652725   

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652725BDBM652725(US20240059691, Example 4440 | 4-chloro-N6-((2-((3-...)
Affinity DataIC50: 2.50E+4nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652725BDBM652725(US20240059691, Example 4440 | 4-chloro-N6-((2-((3-...)
Affinity DataIC50: 7.00E+4nMAssay Description:In vitro inhibition of related proteases was determined using an (C50 assay based on standard literature methods (see e.g. Shori et al., Biochem. Pha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent